全文获取类型
收费全文 | 1461975篇 |
免费 | 118899篇 |
国内免费 | 7435篇 |
专业分类
耳鼻咽喉 | 18799篇 |
儿科学 | 47278篇 |
妇产科学 | 41564篇 |
基础医学 | 206005篇 |
口腔科学 | 38630篇 |
临床医学 | 132768篇 |
内科学 | 291305篇 |
皮肤病学 | 33705篇 |
神经病学 | 119263篇 |
特种医学 | 55608篇 |
外国民族医学 | 497篇 |
外科学 | 215186篇 |
综合类 | 43265篇 |
现状与发展 | 21篇 |
一般理论 | 489篇 |
预防医学 | 114086篇 |
眼科学 | 32781篇 |
药学 | 104397篇 |
69篇 | |
中国医学 | 7247篇 |
肿瘤学 | 85346篇 |
出版年
2021年 | 13870篇 |
2019年 | 13584篇 |
2018年 | 18467篇 |
2017年 | 14592篇 |
2016年 | 15993篇 |
2015年 | 18699篇 |
2014年 | 25647篇 |
2013年 | 36281篇 |
2012年 | 49582篇 |
2011年 | 52344篇 |
2010年 | 31244篇 |
2009年 | 29685篇 |
2008年 | 47233篇 |
2007年 | 49478篇 |
2006年 | 49921篇 |
2005年 | 48120篇 |
2004年 | 45374篇 |
2003年 | 43218篇 |
2002年 | 41463篇 |
2001年 | 74032篇 |
2000年 | 75445篇 |
1999年 | 62457篇 |
1998年 | 17549篇 |
1997年 | 15955篇 |
1996年 | 16014篇 |
1995年 | 15214篇 |
1994年 | 13728篇 |
1993年 | 12784篇 |
1992年 | 46055篇 |
1991年 | 43665篇 |
1990年 | 41643篇 |
1989年 | 39666篇 |
1988年 | 36309篇 |
1987年 | 35462篇 |
1986年 | 32934篇 |
1985年 | 31337篇 |
1984年 | 23844篇 |
1983年 | 20043篇 |
1982年 | 12220篇 |
1981年 | 10790篇 |
1979年 | 20710篇 |
1978年 | 14582篇 |
1977年 | 12086篇 |
1976年 | 11365篇 |
1975年 | 11622篇 |
1974年 | 13989篇 |
1973年 | 13535篇 |
1972年 | 12635篇 |
1971年 | 11470篇 |
1970年 | 10912篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
75.
76.
Michael E Egger Joanna M Ohlendorf Charles R Scoggins Kelly M McMasters Robert C G Martin II 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2015,17(9):839-845
BackgroundThe aim of this paper is to assess the current state of quality and outcomes measures being reported for hepatic resections in the recent literature.MethodsMedline and PubMed databases were searched for English language articles published between 1 January 2002 and 30 April 2013. Two examiners reviewed each article and relevant citations for appropriateness of inclusion, which excluded papers of liver donor hepatic resections, repeat hepatectomies or meta-analyses. Data were extracted and summarized by two examiners for analysis.ResultsFifty-five studies were identified with suitable reporting to assess peri-operative mortality in hepatic resections. In only 35% (19/55) of the studies was the follow-up time explicitly stated, and in 47% (26/55) of studies peri-operative mortality was limited to in-hospital or 30 days. The time period in which complications were captured was not explicitly stated in 19 out of 28 studies. The remaining studies only captured complications within 30 days of the index operation (8/28). There was a paucity of quality literature addressing truly patient-centred outcomes.ConclusionQuality outcomes after a hepatic resection are inconsistently reported in the literature. Quality outcome studies for a hepatectomy should report mortality and morbidity at a minimum of 90 days after surgery. 相似文献
77.
78.
79.
80.
Iclea Rocha Gama Euclides Marinho Trindade-Filho Suzana Lima Oliveira Nassib Bezerra Bueno Isabelle Tenório Melo Cyro Rego Cabral-Junior Elenita M. Barros Jaqueline A. Galvão Wanessa S. Pereira Raphaela C. Ferreira Bruna R. Domingos Terezinha da Rocha Ataide 《Metabolic brain disease》2015,30(1):93-98